Kayode Gabriel Adeyemi

Mr. Kayode Gabriel Adeyemi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2022 in mBio
Verified
Journal Article
Open access
JZJingen Zhu
Jingen Zhu
SJSwati Jain
Swati Jain
JSJian Sha
Jian Sha
HBHimanshu Batra
Himanshu Batra
NANeeti Ananthaswamy
Neeti Ananthaswamy
VRVenigalla B Rao
Venigalla B Rao
According to the World Health Organization, COVID-19 may have caused ~15-million deaths across the globe and is still ravaging the world. Another wave of ~100 million infections is predicted in the United States due to the emergence of highly transmissible immune-escaped Omicron variants.

17 June 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
PSPuthupparampil V Scaria
Puthupparampil V Scaria
CRChristopher G. Rowe
Christopher G. Rowe
IKIvan Kosik
Ivan Kosik
ZHZhe Hu
Zhe Hu
JRJonathan P Renn
Jonathan P Renn
PDPatrick Emmet Duffy
Patrick Emmet Duffy
Background/Objectives: Rapid development of vaccines against SARS-CoV-2 was pivotal to controlling the COVID-19 pandemic. The emergency also provided a rare opportunity to test novel vaccine platforms such as mRNA in large clinical trials. Most of the early vaccines used SARS-CoV-2 Spike protein as the target antigen. Nevertheless, subsequent studies have shown that Receptor Binding Domain (RBD) of Spike also can yield efficacious vaccines, and we previously demonstrated that chemical conjugation of RBD to a carrier protein, EcoCRM®, enhanced antibody responses and induced strong virus neutralization activity in mice. Methods: Here, we compared the immunogenicity of this conjugate to that of an approved mRNA vaccine from Pfizer/BioNTech in rhesus macaques over a period of nine months. Results: AS01-adjuvanted RBD conjugate induced a similar or better antibody response, receptor binding inhibition, and virus neutralization activity against different variants of SARS-CoV-2, compared to mRNA. IgG subclass profiles induced by conjugate and mRNA vaccines were initially dominated by IgG1 and IgG3 then switched to IgG2 and IgG4 dominant profiles during the subsequent six-month period. Polyclonal immune sera from the conjugate and mRNA had similar antibody avidity at multiple time points. Conclusions: In summary, antibody responses in rhesus macaques induced by the RBD-EcoCRM conjugate and the Spike mRNA vaccine are very similar. These results demonstrate the potential for the RBD-EcoCRM conjugate as a vaccine against SARS-CoV-2.

27 May 2021 in International Journal of Modern Anthropology
Verified
Journal Article
Open access
PDF file
KAKayode Gabriel Adeyemi
Kayode Gabriel Adeyemi
Since the World Health Organization announced in early 2020 that the COVID-19 pandemic was accompanied by an infodemic of misinformation, we are left with the question of public perspective-driven compliance to safety measures. This preliminary study evaluated some claims about COVID-19 including vaccine conspiracy theories among Nigerians with factors influencing it. An online structured questionnaire was designed to collect one-time data from voluntary participants. Demographically, major respondents were; bachelor: 284 (75.1%), age-group between 18 and 30 years: 312 (82.5%) and male: 207 (54.8%). Those that do not know the range of infected population in the country accounted for 260 (72.2%). In opinion, 57 (15.1%) supported that SARS-COV-2 cannot survive the warm climate of African continent, and 41 (10.8%) believed the hoax theory about COVID-19. Unapproved herbal medication was reported to be used by 251 (66.4%) of the respondents while 92 (24.3%) made use of Chloroquine. For transmission related conceptions, 52 (13.8%) indicated that an asymptomatic carrier cannot spread the virus to another healthy individual. About half of the respondents 182 (48.1%) suspected that SARS-COV-2 was an engineered virus and 173 (45.8%) supported that there are underlying negative intentions on the clinical trial of COVID-19 vaccines on Africans. There is a weak correlation between the demographic data of the respondents and the claims. The level of misconception Nigerians have about COVID-19 is a major concern. Thus, it is imperative to continuously engage in community awareness and education using proven facts about the virus, and its available prophylaxis measures in order to avoid the dangers that are associated with the prevailing misconceptions. Keywords: Misinformation, Vaccine conspiracy, COVID-19, Compliance

29 August 2023 in Journal of Contemporary International Relations and Diplomacy
Verified
Journal Article
Open access
PDF file
MJMargaret Oluwatoyin Oluwatoyin Japhet
Margaret Oluwatoyin Oluwatoyin Japhet
AOAdebola Ayomude Owolabi
Adebola Ayomude Owolabi
TOTemiloluwa Ifeoluwa Omotade
Temiloluwa Ifeoluwa Omotade
KAKayode Gabriel Adeyemi
Kayode Gabriel Adeyemi
The Covid-19 (coronavirus disease 2019) was caused by SARS-CoV-2, a highly pathogenic, novel zoonotic βcoronavirus. The infection was reported less than a decade after the outbreak of Middle East Respiratory Syndrome (MERS) in 2012, which was reported precisely a decade after SARS-CoV-1 infection, discovered in 2002; the three viruses being zoonotic β-CoVs, leading to severe and potentially fatal respiratory tract infections. COVID-19 started locally in Wuhan but has spread globally to 231 countries within the six habitable continents of the world as of September 22, 2023, affecting health, socio-lifestyle, and economy, leading to changes to accommodate sustainability. A total of 695, 684,448 cases have been recorded with 6,919,216 deaths and 667,700,972 recoveries as of September 2023. This is a global review across the continents of the world, highlighting the epidemiology and impact of the virus as well as human sustainability despite the pandemic.

13 September 2023 in Journal of Biology and Nature
Verified
Journal Article
Closed access
PDF file
ATAmuna O. T.
Amuna O. T.
AEAdebayo T. E.
Adebayo T. E.
ECEzeugwu P. C.
Ezeugwu P. C.
KAKayode Gabriel Adeyemi
Kayode Gabriel Adeyemi
IOItunu S. O.
Itunu S. O.
TDTanko D.
Tanko D.
This study was conducted to determine the prevalence of gastrointestinal parasites in domestic chickens using the abattoir of Mack's farm Osara, Kogi state between January and March 2022. A total of 200 (100 exotic and 100 local breeds with 50 males and 50 females each) faecal samples from the gastro-intestinal tracts of already slaughtered chicken were examined from January to March 2022 using formol-ether concentration technique for the presence of gastrointestinal parasites. Microscopic method was employed for morphological identification of parasite isolates. The result showed that of the 200 samples examined, 178 (89%) were found to be infected with one or more parasites. A higher infection rate of 90 (90%) was found in the local breed than in exotic breed 88(88%). The helminths species found were, Ascaridia galli 66(33.67%), Heterakis gallinarum 44(22.44%), Capillaria Spp 30(15.30%), Gongylonema ingluvocola 20(10.20%), Strongyloides avium 6(3.06%), Raillietina echinobrothrida 6(3.06%), Tricuris tricura 10(5.10%), Choanotaenia infundibulum 10(5.10%) and Coccidian spp 4(2.04%) while the gastrointestinal protozoan isolated was Coccidian spp 4(2.04%). Conclusion: An insignificant difference in parasite prevalence (p >0.05) exists between exotic and local chicken, suggesting potential consumer exposure to infection through cross-infection. This study highlights the risk associated with consuming chicken from poorly managed poultry systems and establishes the need for policymaking toward improved poultry production.